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Abstract
The mechanisms by which receptors guide intracellular virus transport are poorly characterized. The murine polyomavirus
(Py) binds to the lipid receptor ganglioside GD1a and traffics to the endoplasmic reticulum (ER) where it enters the cytosol
and then the nucleus to initiate infection. How Py reaches the ER is unclear. We show that Py is transported initially to the
endolysosome where the low pH imparts a conformational change that enhances its subsequent ER-to-cytosol membrane
penetration. GD1a stimulates not viral binding or entry, but rather sorting of Py from late endosomes and/or lysosomes to
the ER, suggesting that GD1a binding is responsible for ER targeting. Consistent with this, an artificial particle coated with a
GD1a antibody is transported to the ER. Our results provide a rationale for transport of Py through the endolysosome,
demonstrate a novel endolysosome-to-ER transport pathway that is regulated by a lipid, and implicate ganglioside binding
as a general ER targeting mechanism.
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Introduction
Viruses must navigate through the complex endocytic machin-
eries of the host cell to successfully cause infection. Although some
viruses evade or escape degradative compartments such as the
endolysosome to infect cells, others rely on this organelle to
facilitate infection [1]. How these processes are regulated is poorly
understood.
The non-enveloped murine polyomavirus (Py) is transported
from the cell surface to the nucleus where transcription and
replication of the viral DNA genome lead to lytic infection and cell
transformation. The successful arrival of one viral particle to the
nucleus is sufficient to cause infection [2]. Py is composed of 72
pentamers of the outer structural protein VP1, which associate
with the internal proteins VP2 and VP3 and encapsulate the DNA
genome [3].
To initiate infection, VP1 binds to the glycolipid receptor
ganglioside GD1a on the plasma membrane and is transported to
the lumen of the endoplasmic reticulum (ER) [4]. Transport to the
ER is essential for infection as inactivation of ER-resident factors
blocks infection significantly [5–7]. Py then penetrates the ER
membrane, likely enabling it to reach the cytosol and then the
nucleus. The precise mechanism controlling the transport of Py
from the plasma membrane to the ER, a decisive step in the virus
entry pathway, remains to be clarified.
Other members of the polyomavirus family including SV40 and
the human BK virus also bind to ganglioside glycolipids [4,8–10].
This is in contrast to many viruses that rely on glycoproteins as
entry receptors [1,11]. Upon internalization, most gangliosides are
transported to the early and late endosomes, reaching the
lysosome where they are eventually hydrolyzed by lysosomal
enzymes. Although a small fraction of gangliosides can reach the
Golgi from the plasma membrane, their retrograde transport to
the ER has not been observed [12].
Using a combination of live cell fluorescence microscopy,
biochemistry, and cell infection studies, we show that Py is
transported to the endolysosome and that the low pH environment
is critical for infection. Strikingly, we find that GD1a sorts Py from
the endolysosome to the ER. Binding to GD1a is likely the key
event to direct Py to the ER as an artificial particle coated with
GD1a antibody binds to GD1a and is transported to the ER. Our
results provide an explanation for trafficking of Py through the
endolysosome, demonstrate an endolysosome-to-ER transport
pathway that is controlled by a lipid, and implicate ganglioside
binding as a general ER targeting mechanism.
Results
Live cell imaging of polyomavirus transport to the
endolysosome
As GD1a is normally transported through the endolysosome, we
hypothesized that Py binds to this lipid molecule and is also
transported initially through this pathway. To visualize the
transport of Py in murine NIH 3T3 cells in real time, purified Py
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imaged using wide field fluorescence microscopy. We first assessed
whether labeling affected virus entry and infection. We found that,
at 3 hrs post-infection, the fluorescence of the labeled virus in cells
overlapped significantly with the pattern seen with immunofluores-
cence using an antibody against VP1 (Figure 1A). This finding
demonstrates that Py is labeled efficiently and that the dye does not
dissociate from the virus after entry. Next, using expression of the
virally-encoded large T antigen to measure infection, we found that
7.6% of cells infected with the non-labeled virus expressed large T
antigen, and 7.5% of cells infected with the labeled virus expressed
large T antigen (Figure 1B). This result indicates that the labeling
procedure did not affect Py infection, consistent with a previous
observation [13]. We conclude that the labeled Py recapitulates the
normal cellular transport and infection processes of Py.
To determine the subcellular trafficking events that lead to Py
infection, co-localization of labeled virus with fluorescent protein-
tagged markers of the endolysosomal compartments was deter-
mined over time. To synchronize Py infection, cells were
incubated with labeled virus at 4uC to enable cell surface binding,
washed to remove unbound virus, and then shifted to 37uCt o
initiate entry. To rule out any coincident co-localization, the
association of labeled virus with endolysosomal markers was
tracked by live cell imaging. Only those Py particles that co-
localized with vesicles for more than 30 s were counted as true co-
localization.
When the localization of labeled Py was compared to cyan
fluorescent protein (CFP)-Rab5, a marker of early endosomes, we
found that less than 10% of the internalized Py co-localized with
CFP-Rab5 at 0.5–2 hrs post-infection. A relatively low level of
virus persists in the early endosome throughout the course of
infection as seen at the 4–6 hrs and 16–17 hrs post-infection time
points (Figure 1, C and F). The virus appeared to be located on the
endosome membrane, suggesting that it remained attached to the
membrane and was not been released into the lumen (Figure 1C).
These results are consistent with findings in fixed cells where a
minor population of Py co-localized with Rab5-containing early
endosomes [14]. It should be noted that, when expressed at a
moderate level, CFP-Rab5 does not alter significantly the general
morphology or distribution of the EEA1-containing early
endosomes (Figure S1A). This finding is consistent with a previous
report demonstrating that low level expression of GFP-Rab5 does
not affect the size of the early endosomes, or the kinetics of
transferrin uptake and recycling [15].
To assess co-localization of Py with the late endosome, we asked
whether the virus co-localized with yellow fluorescent protein
(YFP)-Rab7, a marker of late endosomes. YFP-Rab7 has been
used previously to study the behavior of the endogenous Rab7
protein [16], and we found that moderate YFP-Rab7 expression
does not affect the general morphology and distribution of the
LAMP1-containing late endosomes and lysosomes (Figure S1B).
Our analysis showed that less than 20% of the internalized Py co-
localized with YFP-Rab7 at 0.5–2 hrs post-infection (Figure 1, D
and F). However, in contrast to early endosomes, Py gradually
accumulated in late endosomes such that up to 70% of Py co-
localized with YFP-Rab7 at later time points (Figure 1F). Similar
results were observed when imaging labeled Py with LAMP1-YFP,
a marker of late endosomes and lysosomes (Figure 1, E and F). In
this case, the extent of co-localization increased from about 12% at
the early time point to 50% at the later time points (Figure 1F,
light blue line). The total percentage of Py that co-localized with
the Rab7- and LAMP1-containing vesicles can exceed 100%
because YFP-Rab7 and LAMP1-YFP are often located on the
same vesicle (data not shown), consistent with a previous
observation [17]. The co-localization of labeled Py with Rab7-
and LAMP1-positive vesicles is in contrast to a previous result in
fixed cells where no co-localization was reported for Py with Rab7-
or LAMP2-containing vesicles [14]. The reason for this conflicting
result is unknown, but could be due to differences in the detection
method or cell type. We also found that Py does not co-localize
with caveolin-1 in NIH 3T3 cells (Figure S2), in agreement with a
previous finding [13]. Thus, we conclude that Py is transported
through the endolysosomal pathway.
Effects of expressing Rab5 and Rab7 mutants on
polyomavirus infection
As Py co-localized extensively with endolysosomal compart-
ments, we asked if transport through these compartments is part of
the Py infectious route. To do this, we took advantage of the fact
that, in addition to providing organelle identity, Rab5 and Rab7
serve critical roles in regulating cargo transport within the
endosomal system [18]. Accordingly, dominant-negative versions
of these proteins have been shown to block cargo transport
[19,20]. We therefore tested the effect of expression of dominant-
negative CFP-Rab5 S34N (CFP-Rab5 DN) on Py infection as
compared to expression of either CFP (control) or wild-type CFP-
Rab5. Whereas expression of CFP-Rab5 did not affect expression
of Py large T antigen when compared to the control, expression of
CFP-Rab5 DN caused a reduction in Py infection (Figure 2A).
This result is consistent with a previous observation in which
expression of dominant-negative Rab5 was reported to reduce Py
infection (as data not shown) in [21]. In addition, we found that
expression of a constitutively active form of Rab5, CFP-Rab5
Q79L, caused a moderate increase in Py infection (Figure 2A,
CFP-Rab5 CA). We conclude that transport through the early
endosome is critical for Py infection.
To assess whether transport to the late endosome plays a role in
virus infection, we used YFP-Rab7 N125I (Rab7 DN), a
dominant-negative Rab7 demonstrated previously to block
transport of the vesicular stomatitis virus G protein from the early
endosome to the late endosome [20]. Expression of YFP-Rab7 DN
caused a decrease in Py infection when compared to control cells
Author Summary
To cause infection, viruses must reach appropriate
compartments within the cell where they undergo a
programmed series of conformational changes that enable
the viral genome to be exposed and released. The
mechanisms that target viruses to these compartments
are often not clear. Here we study the infectious pathway
of the murine polyomavirus (Py). Py is transported from
the cell surface to the intracellular organelle called the
endoplasmic reticulum (ER), where it breaches the ER
membrane to reach the nucleus to stimulate infection.
How Py is transported from the cell surface to the ER is
poorly characterized. Our studies show that Py first enters
the endolysosome compartments before reaching the ER.
The low pH of the endolysosome imparts a structural
change on the virus that facilitates its subsequent ER
membrane penetration. Importantly, transport of Py from
the endolysosome to the ER is guided by the lipid receptor
ganglioside GD1a. We also demonstrate that an artificial
bead capable of binding to GD1a is transported to the ER
as well. Collectively, our data identify a lipid-dependent
mechanism that targets a virus to its appropriate organelle
during infection.
Lipid-Dependent Sorting of Polyomavirus
PLoS Pathogens | www.plospathogens.org 2 June 2009 | Volume 5 | Issue 6 | e1000465Figure 1. Time-dependent transport of Py through the endolysosome. (A) NIH 3T3 cells were incubated with Texas-Red-labeled purified Py
for 3 hrs at 37uC, washed, and subjected to immunofluorescence using a VP1 antibody followed by FITC-labeled secondary antibody. White line, edge
of cell. Scale bar, 5 mm. (B) Cells were incubated with labeled or non-labeled Py for 48 hrs, and the extent of infection assessed by
immunofluorescence using a Py large T antigen antibody. Cells stained with large T antigen in the nucleus were scored as positive for infection. Scale
bars, 30 mm. (C–E) Live cell imaging of labeled Py in cells expressing (C) CFP-Rab5, (D) YFP-Rab7, or (E) LAMP1-YFP. C, D, and E are images taken at the
4–6 hrs post-infection time point. Yellow lines, edge of cells. Scale bars, 10 mm (whole cell) and 1 mm (inset). (F) Quantification of the extent of co-
localization between labeled Py and the respective markers at the indicated post-infection time points. For each time point, at least 90 viral particles
were analyzed from 3 cells. Data are the mean+/2SD.
doi:10.1371/journal.ppat.1000465.g001
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compartment constitutes part of the Py infectious route.
A role of the endolysosomal low pH in Py infection and
conformational change
Transport of Py through the endolysosomal pathway could
indicate that GD1a-bound Py merely follows the ganglioside
trafficking pathways. Alternatively, transit through the acidic
endolysosomal pathway may be critical for the Py infectious
process. To test this possibility, we asked whether the low pH in
these compartments plays a role in Py infection. To this end, cells
were incubated with bafilomycin A1, a specific inhibitor of the
vacuolar proton ATPase that prevents acidification of endosomes,
and its effect on large T antigen expression was measured. We
found a significant reduction in infection in cells treated with
bafilomycin A1 either 2 hrs prior to infection or at infection
(Figure 3A, 2 hrs pre-infection and at infection). In contrast, when
cells were treated with the drug 3 hrs after infection, no effect was
seen (Figure 3A, 3 hrs post-infection). NH4Cl, a weak base that
elevates endolysosomal pH [22], also blocks infection if it was
administered either 2 hrs prior to infection or at infection, but not
3 hrs post-infection (not shown).
Perturbation of endolysosomal pH could interfere with Py
infection in several ways. One possibility is that the low pH is
required for cargo transport from early to late endosomes [23],
such that perturbing the endosomal pH would block virus delivery
to the late endosomes. This block in transport to the late
endosomes would consequently interfere with delivery of the virus
to the ER, a prerequisite step for infection. Alternatively, the low
pH could induce conformational changes that facilitate viral
penetration, as documented in other viral systems [24]. To test the
first possibility, we asked whether blocking acidification of
endosomes with bafilomycin A1 affects co-localization of Py with
the late endosome and the ER using immunofluorescence staining.
Cells expressing YFP-Rab7 were infected with non-labeled Py and
treated with bafilomycin A1 simultaneously. 4.5 hrs post-infection,
cells were fixed and stained with an antibody against Py VP1,
followed by addition of a fluorescently tagged secondary antibody.
The extent of co-localization between the anti-VP1 fluorescent
signal and fluorescence from YFP-Rab7 were assessed. We found
that the level of co-localization between Py and Rab7 in control
and bafilomycin A1-treated cells was similar (Figure 3B, top
panel), indicating that Py transport to the late endosome is not
disrupted by a block in endosomal acidification. This finding is
further supported by the observation that NH4Cl did not disrupt
co-localization of Py and the Rab7-containing endosomes (not
shown). In cells expressing the ER-resident protein heme
oxygenase-2 fused to CFP (CFP-HO2), bafilomycin A1 did not
affect co-localization of Py with the ER as well (Figure 3B, bottom
panel). Collectively, these findings suggest that the endolysosomal
low pH plays a critical role in facilitating Py infection, likely
through acting directly on the virus. It should be noted that, while
a previous finding showed that NH4Cl-treated cells did not block
Py infection [13], another showed that it did [21].
We therefore tested the possibility that the low pH of the
endolysosome imparts a conformational change in Py that
facilitates its subsequent ER-to-cytosol penetration. We first
determined if exposure of Py to a pH approximating the
endolysosomal pH (i.e. pH 6.0 for the early endosomes and 5.0
for the late endosomes/lysosomes) induces structural changes to
the virus using limited proteolysis. Py was incubated at pH 7.5,
6.0, or 5.0, neutralized to pH 7.5, and then treated with a low
concentration of proteinase K (2.5 ng/ml). We found discrete
fragments of VP1 were generated by this protease when Py was
exposed to low pH (Figure 3C, compare lanes 5 and 6 to lane 4).
In addition, Py exposed to low pH was also more sensitive to
digestion with a high trypsin concentration (1 mg/ml) (Figure S3,
bottom panel, compare lanes 2 and 3 to lane 1). These results
indicate that low pH induces a conformational change to VP1,
likely through destabilizing the virus.
We next tested whether the low pH-triggered conformational
change affects an ER-dependent remodeling event critical for Py’s
subsequent ER-to-cytosol penetration process. Our previous work
established an in vitro trypsin digestion assay that measures ER-
dependent remodeling of Py required for penetration [5,25].
Previous structural studies on Py showed that disulfide bonds and
calcium ions stabilize the viral structure [3]; thus, reducing the
disulfide bonds and removing the calcium ions should partially
destabilize the virus. In fact, reduction of the Py disulfide bonds in
the ER was shown to be dependent on PDI [7], while calcium ion
Figure 2. Expression of Rab5- and Rab7-interfering mutants
affects Py infection. NIH 3T3 cells expressing (A) CFP control, wild-
type CFP-Rab5, dominant-negative CFP-Rab5 (DN), or constitutively
active CFP-Rab5 (CA) or (B) YFP control, wild-type YFP-Rab7, or
dominant-negative Rab7 (DN) were incubated with Py. 48 hrs later,
the extent of infection in transfected cells was assayed as in Figure 1B.
Data represent the mean+/2SD of at least four independent
experiments. In Figure 2A, 27/262 cells expressed T antigen in the
CFP-expressing cells. In Figure 2B, 75/464 cells expressed T antigen in
the YFP-expressing cells. A two-tailed t test was used.
doi:10.1371/journal.ppat.1000465.g002
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PLoS Pathogens | www.plospathogens.org 4 June 2009 | Volume 5 | Issue 6 | e1000465Figure 3. Effect of low pH on Py infection and conformational change. (A) NIH 3T3 cells were treated with bafilomycin A1 2 hrs before, at the
same time, or 3 hrs after infection with non-labeled Py, and washed to remove the drug. 48 hrs later, the extent of large T antigen expression was
determined as in Figure 1B. Infection efficiency was normalized to the control cells. 37/1021 cells expressed large T antigen in the control cells. A two-
tailed t test was used. Data are the mean+/2SD. (B) Cells expressing YFP-Rab7 (top) or CFP-HO2 (bottom) were infected with non-labeled Py and
treated with bafilomycin A1 simultaneously. 4.5 hrs post-infection, cells were fixed and stained with an antibody against Py VP1, followed by addition
of a fluorescently tagged secondary antibody; the extent of co-localization between this fluorescent signal and the fluorescence from YFP-Rab7 or
Lipid-Dependent Sorting of Polyomavirus
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proteins, calnexin/calreticulin. Hence, in the in vitro assay, Py was
initially incubated with the reducing agent DTT, the calcium-
chelating agent EGTA, and the control protein bovine serum
albumin (BSA). Under this condition, addition of a low trypsin
concentration (0.25 mg/ml) resulted in appearance of a VP1-
derived fragment called VP1a (Figure 3D, lane 2) [5]. In contrast,
incubation of Py with an extract containing ER lumenal proteins
(ER lumenal extract) instead of BSA generated an additional
cleavage product called VP1b (Figure 3D, lane 4) [5]. We now find
that VP1b formation generated by treatment with the ER lumenal
extract was increased by pre-exposure of Py to low pH (Figure 3D,
compare lane 8 to lane 6, and in duplicates, compare lane 12 to
lane 10; quantified in right graph). As formation of the VP1b
fragment reflects an ER-dependent conformational change that
initiates ER-to-cytosol membrane penetration of Py, we conclude
that the endolysosomal low pH enhances this event critical for
infection.
Decreased co-localization of Py with the late endosome
and lysosome in cells supplemented with GD1a
Our results indicate that trafficking of Py through the low pH
environment of endolysosomal compartments is critical for the
infection processes. What is the molecular mechanism by which Py
is transported through these membrane-bound compartments?
The lipid receptor GD1a has been shown to stimulate infection in
the ganglioside-deficient C6 cell line [4,9], yet the step(s) in Py
infection facilitated by the ganglioside are largely unknown. Thus,
we asked whether GD1a promotes infection by affecting viral
trafficking along the endolysosomal pathway.
We first verified that supplementing GD1a could stimulate Py
infection in NIH 3T3 cells, as shown previously in C6 cells [4,9].
Cells were incubated with either GD1a or the control ganglioside
GM1 overnight, washed to remove unbound gangliosides, and
then incubated with Py. At 48 hrs post-infection, cells were
analyzed for large T antigen expression. As expected, Py infection
was increased in cells supplemented with GD1a, but not GM1
(Figure 4A).
We then asked whether the increase in infection in GD1a-
supplemented cells is due to enhanced virus binding and entry. To
assess viral binding to the plasma membrane, control or GD1a-
supplemented cells were incubated with Py at 4uC to allow surface
binding, washed to remove the unbound virus, harvested, and the
cells treated with or without proteinase K. Surface-bound virus
should be sensitive to proteolysis. The proteinase K was
inactivated, and the total cell lysate subjected to SDS-PAGE
followed by immunoblotting with a VP1 antibody. We found a
similar VP1 binding level between GD1a-supplemented and
control cells (Figure 4B, compare lane 2 to 1), and the VP1 were
completely sensitive to proteinase K digestion (Figure 4B, lanes 3
and 4), as expected. These results indicate that GD1a did not
stimulate cell surface binding of Py, consistent with a previous
result in C6 cells [9]. The lack of increased viral binding in GD1a-
supplemented cells is likely due to Py VP1 binding to the sialic
acid-galactose moiety present in both GD1a and glycoproteins on
the cell surface [3,4].
We next assessed whether GD1a promoted entry of Py. Cells
incubated with Py at 4uC were shifted to 37uC for 1 hr to allow
viral entry before treatment with proteinase K. Internalized virus
should be resistant to proteinase K digestion. GD1a supplemen-
tation caused no increase in protease-resistant VP1 levels when
compared to the control cells (Figure 4B, compare lane 8 to 7),
suggesting that GD1a did not stimulate cell entry. We conclude
that GD1a addition stimulated Py infection without increasing
virus binding or entry, perhaps by facilitating transport of
internalized Py to the infectious route.
We thus asked whether GD1a addition affected the co-
localization of Py with early and late endosomal compartments.
At both the early (0.5–2 hrs) and late (4–6 hrs) post-infection time
points, GD1a addition resulted in no difference in the extent of co-
localization of Py with the Rab5-containing early endosome
(Figure 4C), suggesting that GD1a supplementation does not affect
Py transport through early endosomal pathways. Surprisingly, a
significant decrease in co-localization of Py with Rab7-containing
late endosomes was observed at the 4–6 hrs post-infection time
point in GD1a-supplemented cells (Figure 4D). A similar decrease
in late endosomal localization upon GD1a addition was observed
in C6 cells even at 1–2 hrs post-infection (Figure 4E) where a high
percentage of Py (approximately 70%) already co-localized with
Rab7-containing vesicles in control cells. Trafficking of Py to the
late endosome in the ganglioside-deficient cells suggests that non-
ganglioside receptors such as glycoproteins can mediate Py entry
along the endocytic pathway. GD1a addition also caused a
decrease in co-localization of Py with LAMP1-containing vesicles
at the 4–6 hrs time point in NIH 3T3 cells (Figure 4F). To verify
that the decrease in late endosomal localization of Py upon GD1a
supplementation was not due to GD1a-induced constriction of
membrane-bound compartments, we measured the size of CFP-
Rab5, YFP-Rab7, or LAMP1-YFP vesicles in control or GD1a-
supplemented cells and found no significant differences (Figure S4
A–C). Taken together, these results indicate that GD1a supple-
mentation caused a decrease in the co-localization of Py with late
endosome and lysosome compartments.
To exclude the possibility that addition of GD1a creates a novel
infectious pathway that does not require the endolysosome, we
asked whether transport through this compartment is still required
for Py infection in GD1a-supplemented cells. We found that
expression of YFP-Rab7 DN decreased infection in GD1a-
supplemented cells (Figure 4G), similar to the results in control
cells (Figure 2B). Thus, in GD1a-supplemented cells, transport
through the endolysosome remains critical for infection.
That addition of GD1a to cells stimulates Py infection by
decreased co-localization of Py with the late endosome and
lysosome suggests that GD1a functions to sort Py out of the
endolysosome for productive infection.
GD1a stimulates transport of Py to the ER
As trafficking to the ER is required for successful Py infection
[5–7], we tested whether the GD1a-mediated decrease in co-
localization of Py with endolysosome results in increased ER
localization of Py. We used two different methods to analyze co-
localization of Py with the ER: live cell tracking and immunoflu-
CFP-HO2 were assessed. Data are the mean+/2SD. (C) Py was incubated at pH 7.5, 6.0, or 5.0, neutralized to pH 7.5, and then treated with a low
concentration of proteinase K (2.5 ng/ml). The samples were immunoblotted with an antibody against VP1. (D) Py pretreated at pH 7.5 (top and
bottom panels) or at pH 5 (bottom panel) was incubated with DTT, EGTA, and either BSA or an ER lumenal extract, and then treated with a low
trypsin (0.25 mg/ml) concentration. Appearance of the ER-induced VP1b fragment was analyzed by immunoblotting with an antibody against VP1.
Graph on the right represents quantification of the relative VP1b level generated from Py pretreated at pH 7.5 or 5. A two-tailed t test was used. Data
are the mean+/2SD.
doi:10.1371/journal.ppat.1000465.g003
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PLoS Pathogens | www.plospathogens.org 6 June 2009 | Volume 5 | Issue 6 | e1000465Figure 4. Decreased co-localization of Py with the late endosome and lysosome in GD1a-supplemented cells. (A) NIH 3T3 cells were
incubated with purified GM1 or GD1a, washed, infected with Py, and the extent of infection was assessed as in Figure 1B. Results were normalized to
non-supplemented cells (control cells). In the control cells, 43/984 cells expressed large T antigen. (B) Untreated (control) or GD1a-supplemented NIH
3T3 cells were incubated with Py at 4uC to allow viral binding and then treated with proteinase K where indicated (top panel) or incubated at 37uC for
1 hr before proteinase K treatment to determine viral entry (bottom panel). (C, D) The extent of co-localization of labeled Py with (C) Rab5-containing
vesicles or (D) Rab7-containing vesicles at the early (0.5–2 hrs) and late (4–6 hrs) time points in both control and GD1a-supplemented NIH 3T3 cells.
(E) Co-localization of labeled Py with Rab7-containing vesicles at 1–2 hrs post-infection in the ganglioside-deficient C6 cells. (F) Co-localization of
Lipid-Dependent Sorting of Polyomavirus
PLoS Pathogens | www.plospathogens.org 7 June 2009 | Volume 5 | Issue 6 | e1000465orescence staining. First, using the live cell tracking approach, cells
co-expressing CFP-HO2 and YFP-Rab7 were supplemented with
or without GD1a, and infected with labeled Py. The extent of co-
localization of Py with the ER was analyzed 4–6 hrs post-infection.
As the ER tubules are highly convoluted in NIH 3T3 cells, the
images were filtered (Figure S5) to define the boundaries of the ER
tubules and allow a more accurate analysis of Py co-localization. A
typical example of a filtered image depicting co-localization of Py
with the ER in real time is shown in Figure 5A. Using this method
of analysis, we found that when the cells were incubated at 4uCt o
prevent endocytosis of the virus, no co-localization between Py
and the ER was observed (Figure 5B). By contrast, an increased
level of co-localization was found if the temperature was raised to
37uC (Figure 5B). At this temperature, addition of brefeldin A
(BFA), a drug that blocks retrograde COPI-dependent transport
between the Golgi complex and the ER, decreased the level of Py-
ER co-localization. These data demonstrate that the level of co-
localization observed between Py and ER at 37uC was specific and
not due to random co-localization. Importantly, co-localization of
Py with the ER increased in cells supplemented with GD1a when
compare to non-supplemented cells (Figure 5B). This finding
suggests that GD1a promotes transport of Py to the ER, consistent
with a previous observation in C6 cells [9]. Moreover, by
immunofluorescence staining, we found that the extent of co-
localization between Py and the ER increased in GD1a-
supplemented cells when compare to non-supplemented cells
(Figure 5C; quantified below), similar to results from live cell
tracking. These data collectively support the contention that GD1a
targets Py from the endolysosome to the ER.
That GD1a caused an increase in the amount of Py which co-
localized with the ER raises the possibility that trafficking of virus
from the late endosome and/or lysosomes to the ER is part of the
infectious pathway. This model predicts that disruption of virus
trafficking to the endolysosome should hinder subsequent
transport to the ER. Indeed, we found that the extent of Py co-
localization with the ER decreased in cells expressing YFP-Rab7
DN when compared to YFP-Rab7 WT (Figure 5D). As a control,
we show that expression of YFP-Rab7 DN does not affect
transport of the non-endosomal cargo cholera toxin B subunit
(CTB) to the ER (Figure 5E). We conclude that the endolysosome
is an intermediate destination during the plasma membrane-to-ER
transport of Py and that GD1a functions to sort the virus from the
endolysosome to the ER.
Transport of an artificial particle coated with a GD1a
antibody to the ER
How does Py reach the ER? As many polyomaviruses including
Py, SV40, and BK virus, and bacterial toxins such as cholera
toxin, bind to gangliosides and are transported to the ER
[4,10,26], we hypothesized that ligand interaction with ganglio-
sides is sufficient to drive the ligand to the ER.
To test this possibility, we asked whether an artificial particle
designed to bind GD1a in a multivalent fashion, hence mimicking
a viral particle, could be transported to the ER. A fluorescent
particle Quantum-dot (Q-dot) approximately 20 nm in diameter
(the diameter of Py is 45 nm) was coated with either a low
(0.1 mg/ml), middle (1 mg/ml), or high (10 mg/ml) concentration
of a GD1a antibody (Q-dot:GD1a Ab). The ability of Q-dot:GD1a
Ab particles to bind to GD1a was verified using a sucrose flotation
assay used previously to demonstrate Py binding to GD1a [4]. Q-
dot:GD1a Ab (high) particles were incubated with liposomes or
liposomes containing purified GD1a, and the samples floated in a
sucrose gradient. Fractions from the gradient were analyzed for
the presence of the GD1a antibody heavy chain present on the
GD1a Ab-labelled Q-dot. Flotation of Q-dot:GD1a Ab beads to
the top fractions was seen with liposomes containing GD1a but not
with liposomes only (Figure 6A), indicating that the Q-dot coated
with GD1a antibodies can bind to GD1a gangliosides.
We then used live cell imaging to analyze the localization of
various antibody-coated Q-dots to the plasma membrane and the
ER in NIH 3T3 cells. Q-dot:GD1a Ab (low), Q-dot:GD1a Ab
(middle), and Q-dot:GD1a Ab (high), as well as a Q-dot coated
with 10 mg/ml of the control Myc (Q-dot:Myc Ab high) or
10 mg/ml of transferrin receptor (TfR) (Q-dot:TfR Ab high)
antibodies, were incubated in GD1a supplemented-cells. When
the Q-dots were incubated with cells at 4uC to assess plasma
membrane binding, we found approximately 40 Q-dot:Myc Ab
(high) and 880 Q-dot:TfR Ab (high) on the surface per cell
(Figure 6B). By contrast, approximately 500 Q-dot:GD1a Ab
(low), 1000 Q-dot:GD1a (middle), and 2200 Q-dot:GD1a Ab
(high) bound to the surface per cell (Figure 6B). We conclude that
Q-dots coated with a GD1a antibody bound to the plasma
membrane in a concentration-dependent manner, presumably
through interaction with GD1a on the cell surface.
Upon shifting the temperature to 37uC to allow entry, only Q-
dot coated with GD1a antibody, but not Q-dot coated with Myc
or TfR antibodies, can be found to co-localize with the ER
(Figure 6C, left). Quantification showed that, while no Q-dot:Myc
Ab (high) or Q-dot:TfR Ab (high) was found in the ER,
approximately 2% of the internalized Q-dot:GD1a Ab (low), 5%
of the internalized Q-dot:GD1a Ab (middle), and 6% of the
internalized Q-dot:GD1a Ab (high) reached the ER (Figure 6C,
right graph). It should be noted that, under the same condition,
approximately 10% of the Py is targeted to the ER (Figure 5B). As
a control, we found less than 1% of Q-dot:GD1a Ab (high) in the
ER when the Q-dots were incubated with cells at 4uC ( a condition
that prevents endocytosis) (Figure 6C, right graph). In addition,
approximately 1% of Q-dot:GD1a Ab (high) co-localized with the
ER when the Q-dots were incubated at 37uC in the presence of
BFA (a condition that blocks cargo transport to the ER). These
findings demonstrate that the extent of co-localization of Q-
dot:GD1a Ab (high) with the ER detected at 37uC is not random,
but specific. As an artificial particle coated with a GD1a antibody
can bind to GD1a and be transported to the ER, we conclude that
binding to GD1a is the fundamental mechanism for ER targeting.
Discussion
During entry, viruses must be sorted to the appropriate cellular
compartments and undergo a series of conformational changes
that enable them to deliver the viral genome to the cytosol or
nucleus. The cellular machineries that deliver the viruses to the
correct organelles for infection are poorly characterized. The
murine Py is transported from the cell surface to the ER, from
where it is thought to penetrate the ER membrane to access the
cytosol [27] and then the nucleus to cause infection. How Py is
labeled Py with LAMP1-containing vesicles 4–6 hrs post-infection in NIH 3T3 cells. (G) The extent of Py infection in GD1a-supplemented cells
expressing wild type YFP-Rab7 or dominant negative YFP-Rab7 (DN). At least 220 transfected cells were analyzed from three independent
experiments. All data are the mean+/2SD. A two-tailed t test was used.
doi:10.1371/journal.ppat.1000465.g004
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PLoS Pathogens | www.plospathogens.org 8 June 2009 | Volume 5 | Issue 6 | e1000465Figure 5. Increased co-localization of Py with the ER in GD1a-supplemented cells. (A) Live cell imaging of labeled Py co-localization with
the ER. NIH 3T3 cells co-expressing CFP-HO2 and YFP-Rab7 were infected with labeled Py and the extent of co-localization of Py with the ER was
analyzed 4–6 hrs post-infection. The images of the ER were subjected to filtering (see Figure S5) to more clearly define the ER tubule boundaries.
Scale bar, 1 mm. (B) Quantification of Py and ER co-localization in GD1a (4uC, 37uC, BFA+37uC) and GD1a-supplemented cells. More than 300 viral
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PLoS Pathogens | www.plospathogens.org 9 June 2009 | Volume 5 | Issue 6 | e1000465Figure 6. Quantum-dot coated with a GD1a antibody is transported to the ER. (A) Q-dot GD1a Ab (high) was incubated with liposomes or
liposomes containing GD1a. Samples were floated in a sucrose gradient, fractionated, subjected to SDS-PAGE, and immunoblotted for the GD1a
antibody heavy chain. (B) Q-dot:Myc Ab (high), Q-dot:TfR Ab (high), Q-dot:GD1a Ab (low), Q-dot:GD1a Ab (middle), and Q-dot:GD1a Ab (high) were
incubated with GD1a-supplemented cells at 4uC, washed to remove unbound Q-dots, and imaged. Left panels, representative images. Yellow lines,
edge of cells. Scale bars, 10 mm for bright field image, and 2 mm for Q-dot image. Right panel, quantification of the indicated Q-dot binding to the
plasma membrane from at least 3 cells. Data are mean+/2SD. (C) Co-localization of Q-dot:GD1a Ab (high) with CFP-HO2 in GD1a-supplemented NIH
3T3 cells. Left panel, representative images (ER image processed as in Figure 5A). Scale bar, 2 mm. Right panel, quantification of the indicated Q-dot
co-localizing with the ER at various conditions from at least 3 different cells. Data are the mean+/2SD. A two-tailed t test was used.
doi:10.1371/journal.ppat.1000465.g006
particles were analyzed from at least 5 different cells. (C) Py and ER co-localization in control and GD1a-supplemented cells using
immunofluorescence staining. Scale bar, 2 mm. (below) Quantification of the extent of co-localization, normalized to control cells. Arrowhead, Py
that co-localized with the ER. Arrow, Py that did not co-localize with the ER. (D) Quantification of Py and ER co-localization in cells expressing either
wild-type YFP-Rab7 (WT) or dominant-negative YFP-Rab7 (DN) using live cell tracking, as in A. The extent of co-localization was normalized to wild-
type Rab7 expressing cells. (E) Quantification of CTB and ER co-localization in cells expressing either wild-type YFP-Rab7 or dominant-negative YFP-
Rab7. Data are the mean+/2SD. A two-tailed t test was used.
doi:10.1371/journal.ppat.1000465.g005
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results here demonstrate that Py is transported to the endolyso-
some where it experiences a conformational change that enhances
its subsequent ER membrane penetration process (Figure 7).
Importantly, we identify a novel transport pathway in which
ganglioside GD1a sorts Py from the endolysosome to the ER.
Finally, our findings implicate ganglioside binding as a general ER
targeting mechanism. We will discuss these three points separately.
Transport to the endolysosome
Using live cell imaging approaches, our study indicates that Py
is transported through the early and late endosomes, finally
reaching the lysosome. The kinetic analysis suggested that the rate
of Py transport to the endosomal compartments is significantly
slower than the rate observed for classic ligand-receptor
complexes, such as the low-density lipoprotein (LDL)-LDL
receptor and transferrin-transferrin receptor complexes. For
instance, whereas Py begins to accumulate in the late endosome
and lysosome 0.5–2 hrs post-infection, the entire process of
delivering the LDL-LDL receptor complex to the late endosome
(where LDL is released from the receptor) followed by recycling of
the receptor to the plasma membrane is accomplished in 12 min
[28]. Similarly, endocytosis of the transferrin-transferrin receptor
complex to the late endosome and recycling of this complex to the
cell surface is completed in 16 min [29]. Factors that account for
the slow rate of Py internalization are presently unclear. A
previous study suggested that transport of ganglioside from the cell
surface to the lysosome takes place in approximately 10–
15 minutes [30]. Thus it is unlikely that the intrinsic rate of
ganglioside transport to the endolysosome accounts for Py’s slow
internalization into this compartment. Instead, it is likely that the
relatively large size of the viral particle hinders the transport
process.
We observed that a small portion of Py remained associated
with the early endosomes for a prolonged period of time. In this
context, it is interesting to note that a study had shown previously
the existence of two populations of early endosomes [31]. Some
cargoes are transported in vesicles called the static early
endosomes, while other cargoes are transported in rapidly
maturing early endosomes called the dynamic early endosomes.
Sorting of Py to these dynamic early endosomes may represent the
infectious route, while Py trapped within the static early
Figure 7. Model for sorting of Py from the plasma membrane to the ER. Polyomavirus binds to ganglioside GD1a or non-ganglioside
receptors at the plasma membrane and is transport to the endolysosome. The low pH in this environment induces a conformational change on the
virus that facilitates its subsequent structural alteration in the ER. Py that is bound to GD1a in the endolyosome is sorted to the ER where it undergoes
an ERp29-dependent structural change [5] that initiates viral penetration across the ER membrane.
doi:10.1371/journal.ppat.1000465.g007
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productive infection.
A significant level of Py eventually reaches the late endosome
and lysosome. This observation suggests that transport to these
compartments provides a strategic advantage to Py during
infection. Indeed, we found that the low pH in the endolysosome
imparts a conformational change in Py that enables it to more
efficiently undergo an ER remodeling reaction which is crucial for
the ER-to-cytosol membrane penetration event [5,25]. That
blocking acidification of the endolysosome by bafilomycin A1
decreased Py infection is consistent with the results of one study
[21]. However, another study found that elevating endolysosomal
pH with NH4Cl did not affect virus infection [13], in contrast to
findings that NH4Cl blocks virus infection in [21] and our present
study (not shown). This discrepancy may be due to differences in
methodology, and the high infection levels in [13] may render Py
infection resistant to NH4Cl treatment. The nature of the low pH-
induced Py conformational change is presently unknown, although
it is likely irreversible as it was detected after neutralization. One
possibility is that, as calcium ions have been proposed to stabilize
Py structure [32], low pH-induced protonation of the Glu and Asp
residues that ligate calcium ions may trigger the release of calcium,
effectively destabilizing the virus.
In addition to Py, human JC and BV virus infection are also
sensitive to elevation of the endolysosomal low pH [33,34],
implicating the endolysosome as part of their infection pathway.
By contrast, SV40 infection is pH independent [33]. This finding
is consistent with the observation that SV40 is transported to a
pH-neutral compartment called the caveosome prior to reaching
the ER [35]. Whether GM1, the receptor for SV40 [4], sorts SV40
from the caveosome to the ER requires further study.
A role of GD1a in the endolysosome-to-ER transport of Py
Our data indicate that, in addition to its role in cell surface
binding of Py, GD1a also plays a critical function in the
intracellular trafficking of Py. As GD1a is transported normally
to the endolysosome, GD1a likely carries Py from the plasma
membrane to the endolysosome. However, delivery of Py to the
endolysosome does not appear to be GD1a’s critical function as Py
can be transported to the endolysosome in ganglioside-deficient
cells. This finding suggests that non-ganglioside receptors such as
glycoproteins can also deliver Py to the endolysosome (Figure 7).
Instead, our analysis demonstrates that the crucial role of GD1a is
to sort Py from the endolysosome to the ER to facilitate infection;
Py bound to non-ganglioside receptors is likely trapped in the
endolysosome.
Proteins that traffic from the ER to the late endosome/lysosome
normally pass through the trans Golgi. In this context, we have not
observed co-localization of Py with the Golgi (not shown), similar
to a previous report [9]. Whether Py-containing vesicle that is
sorted out of the endolysosome fuses directly with the ER
membrane or with another vesicle which then fuses with the ER
membrane, is unknown.
The proposed endolysosome-to-ER transport pathway is not
without precedent. For example, under a pathological condition
where gangliosides in the lysosome are not degraded, these lipids
are transported to the ER and induce the unfolded protein
response [36]. Furthermore, during replication of the intracellular
pathogen Brucella abortus, the Brucella containing vacuole which
represents a phagosome fuses with the late endosomes and recruits
late endosomal markers. This vacuolar maturation process is
required to traffic to the ER to enable subsequent bacterial
replication [37]. Interestingly, the reverse pathway in which
molecules are transported from the ER to the endolysosome
independent of the Golgi was recently described in the trafficking
of toll-like receptors [38]. These findings collectively implicate the
existence of a previously unappreciated transport pathway
between the endolysosome and the ER.
It remains unclear whether GD1a sorts Py out of the early
endosome or the late endosome/lysosome. Our data show that
transport to the late endosome is crucial for Py infection, and that
GD1a decreased Py co-localization with the late endosome and
lysosome. The simplest interpretation of these findings is that Py is
sorted out of the late endosome/lysosome. However, it is
conceivable that a block in transport to the late endosome
interfered with upstream sorting processes in the early endosome.
Further analysis is required to distinguish between these two
possibilities.
Lipid rafts/caveolae were shown previously to play a role in the
GD1a-mediated Py infection pathway in the rat glioma C6 cells
[9]. In this context, we did not detect any significant co-
localization of Py with caveolae in mouse NIH 3T3 fibroblasts.
Nonetheless, it remains possible that the endolysosome and the
raft/caveolae-mediated pathways intersect to facilitate Py infec-
tion. In fact, recent findings demonstrate a complex crosstalk
system between these two pathways traditionally viewed as
independent [39,40].
Ganglioside binding as a general ER targeting
mechanism
What might be the molecular mechanism by which GD1a sorts
Py from the endolysosome to the ER? Because the 360 VP1
molecules of Py provide 360 GD1a binding sites, each virus likely
binds to multiple gangliosides on the cell surface. In addition, as
gangliosides are normally internalized and transported to the
endolysosome, Py may recruit even more GD1a during its
transport to the endolysosome. This process clusters multiple
molecules of GD1a on a single viral particle.
GD1a clustering may lead to two potential sorting mechanisms.
First, clustering results in the formation of a hydrophobic platform
within the bilayer, which can stimulate transmembrane signaling
to recruit cytoplasmic factors that mediate budding of Py-
containing vesicles from the endosomal membrane. Because
gangliosides are only inserted into a single leaflet, any potential
transmembrane signaling would be facilitated by interactions with
a transmembrane protein. Alternatively, ganglioside clustering
may alter the physical properties of the membrane beneath the
virus, causing membrane invagination followed by budding. This
concept was recently demonstrated for shiga toxin, where toxin
binding to its ceramide-based glycolipid GB3 receptor induced
tubular membrane invaginations [41].
Many bacterial toxins, such as CT [26], also bind to ganglioside
receptors and are transported to the ER. Their receptor-binding B
subunits are often pentameric, enabling each toxin to bind to five
ganglioside molecules. Thus toxin-induced clustering of ganglio-
sides likely targets the toxin to the ER, as was recently implicated
for CT [42]. We used an artificial particle designed to bind and
cluster GD1a, and showed that it can be transported to the ER.
This finding supports the principle that ganglioside binding and
clustering provides the fundamental mechanism for ER targeting.
In conclusion, using a model murine fibroblast cell line (NIH
3T3), we have demonstrated that Py is transported to the
endolysosome and then sorted to the ER by the lipid molecule
GD1a to cause infection. As Py induces tumors in a variety of cell
types, including cells of the mammary gland, salivary gland, and
thymus [43], future experiments will clarify whether the
endolysosome-to-ER pathway is observed similarly in these other
cell types.
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Materials
Purified Py, and antibodies against VP1 and large T antigenwere
provided by Tom Benjamin (Harvard Medical School). The CFP-
Rab5a, dominant negative CFP-Rab5a (S34N), constitutively active
CFP-Rab5a (Q79L), YFP-Rab7, dominant negative YFP-Rab7
(N125I) and LAMP1-YFP constructs were generous gifts from Joel
Swanson (University of Michigan). The CFP-Heme Oxygenase-2
construct was from Melissa Rolls (Penn State). A monoclonal
antibody against GD1a was purchased from Millipore, purified
GD1a and GM1 from Matreya, monoclonal Myc antibody,
Quantum dots 655, Texas Red-X, and Alexa Fluor 594 from
Invitrogen, and proteinase K, trypsin, and NH4Cl from Sigma.
Preparation of Texas Red or Alexa Fluor 594 labeled Py
Purified Py was labeled with Texas Red–X succinimidyl ester
(1 mM) or Alexa Fluor 594 succinimidyl ester (1 mM) following
the manufacturer’s protocol (Invitrogen). The labeled Py was
separated from excess labeling reagent using a Micro Bio-Spin 30
Column (Bio-Rad Lab).
Preparation of Quantum dot coated with a GD1a, Myc, or
TfR antibody
Quantum dot 655 (goat F (ab’) 2 anti-mouse IgG conjugate)
(1 mM) was incubated with a monoclonal antibody against GD1a
(0.1, 1, or 10 mg/ml), Myc (10 mg/ml), or TfR (10 mg/ml) in
30 ml PBS at 4uC for 16 hrs with mixing. Protein A agarose beads
were added to the sample to precipitate the excess GD1a, Myc, or
TfR antibodies. GD1a-, Myc-, or TfR-coated Quantum dots were
present in the resulting supernatant.
Infection assay
NIH 3T3 cells were transfected using Effectene (Qiagen) with
constructs encoding wild-type and mutant CFP-Rab5, or wild-type
and mutant YFP-Rab7. 24 hrs post-transfection, cells were
incubated with Py (multiplicities of infections were approximately
100 PFU/cell or 1610
4 particles/cell), washed after 24 hrs, and
incubated for an additional 24 hrs. Cells were then fixed and
subjected to immunofluorescence (IF) with an antibody against the
virus-encoded large T antigen. Phase and IF images were collected
with a Nikon TE2000-E microscope using the Plan Fluor Ph2
406/Na 0.75 objective. Only those cells expressing the transfected
protein were analyzed. Where indicated, GD1a (180 mM) or GM1
(180 mM) were incubated for 24 hrs prior to infection. For
characterizing the effect of bafilomycin A1 and NH4Cl on Py
infection, cells were treated with bafilomycin A1 (0.2 mM) or
NH4Cl (50 mM) 2 hrs pre-infection, simultaneously with infec-
tion, or 3 hrs post-infection. Cells were then infected with crude Py
for 3 hrs and the unbounded virus was removed by washing. The
cells were incubated at 37uC for additional 48 hrs, fixed and
subjected to T antigen expression analysis.
Time-lapse live fluorescence microscopy and image
analysis
NIH 3T3 cells were transfected using Effectene (Qiagen) with
the indicated constructs for 1 to 2 days, and where indicated,
GD1a was added 24 hrs pre-infection. Cells were incubated with
labeled Py (or Q-dot) at 4uC for 0.5 hr and the unbounded virus
(or Q-dot) was removed by washing. The cells were incubated at
37uC for the indicated time, and observed with a Nikon TE2000-E
microscope equipped with 1006objective. Images were acquired
at 5 s or 10 s intervals.
For co-localization of Py (or Q-dot) and endolysosomal markers
(CFP or YFP), different color images were taken sequentially with
Nikon filter cubes for Texas Red (96313), CFP (96341) and YFP
(96345). For co-localization of Py with ER (CFP-HO2), the ECFP/
DsRed filter set (51018, Chroma) was used to simultaneously image
the two colors. The dual-color image was split to two channels by
Dual-View image splitter (Optical Insight) and projected to the two
halves of a CCD camera (CoolSnap EZ
2, Photometrics). To correct
the imaging mis-alignment between different channels, Py or Q-dot
images were registered to the other channels by bilinear
transformation. To define the boundaries of the ER clearly, the
ER images were subjected to filtering with the Fast Fourier
Transform Bandpass Filter embedded in Image J (NIH). The
filtering settings were set to 15 pixels with large structures and up to
3 pixels with small structures, and a tolerance of direction of 5%.
Co-localization was defined as overlapping of the objects of interest
in the two channels for at least 30 s in a movie.
Immunofluorescence staining
Cells were fixed with formaldehyde (3%), permeabilized with
Triton X-100 (0.2%), and incubated with either an antibody
against Py large T antigen or VP1. Cells were then washed, and
incubated with a fluorescently tagged secondary antibody
(rhodamine labeled donkey anti-rat (for large T) or anti-rabbit
(for VP1).
Cell surface binding and entry
Control or GD1a-supplemented cells were incubated at 4uC,
infected with Py, and either continued to be incubated at 4uC for
1 hr or incubated at 37uC for 1 hr to allow entry. Cells were
harvested and treated with proteinase K (30 mg/ml) where
indicated. Proteinase K was heat-inactivated, and the lysate was
subjected to SDS-PAGE followed by immunoblotting with a VP1
antibody.
Low pH-induced Py conformational change
Py was initially incubated in phosphate buffered saline (PBS) at
pH 7.5, 6.0, or 5.0 for 60 min at 37uC. Virus incubated at pH 6.0
or 5.0 were then neutralized to pH 7.5 by addition of PBS
(pH 10.0). The virus was subsequently incubated with a low
concentration of proteinase K (2.5 ng/ml) or a high concentration
of trypsin (1 mg/ml) for 30 min at 4uC, and subjected to SDS-
PAGE followed by immunoblotting with a VP1 antibody.
ER-dependent conformational change
Py incubated at pH 7.5, or pretreated at pH 5 and neutralized
to pH 7.5, was analyzed as described in [5].
Sucrose flotation of Q-dot
Sucrose flotation analysis is described in [4], except that Q-dot
coated with a GD1a antibody was used instead of Py, and a
monoclonal secondary antibody fused to HRP was used during
immunoblotting.
Supporting Information
Figure S1 Morphology and distribution of early endosomes in
CFP-Rab5 expressing cells, and of the late endosomes/lysosomes
in YFP-Rab7 expressing cells. (A) A non-transfected cell (arrow
head) and a cell expressing CFP-Rab5 (arrow) were fixed and
stained with an antibody against the early endosomal marker
EEA1, followed by addition of a fluorescently tagged secondary
antibody. The fluorescent signal from this antibody and CFP-
Rab5 are shown. (B) As in A, except cells are expressing YFP-
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marker LAMP1 was used. Scale bar, 10 mm.
Found at: doi:10.1371/journal.ppat.1000465.s001 (2.79 MB TIF)
Figure S2 Lack of Py and caveolin-1 co-localization in NIH 3T3
cells. Cells expressing caveolin-1-mCitrine were incubated with Py
for 20 min, fixed and stained with an antibody against Py VP1.
Caveolin-1-mCitrine in green and Py in red.
Found at: doi:10.1371/journal.ppat.1000465.s002 (1.33 MB TIF)
Figure S3 Effect of low pH on polyomavirus conformational
change. Py incubated with the indicated pH were neutralized and
incubated with a high trypsin (1 mg/ml) concentration (bottom
panel) or untreated (top panel). The samples were immunoblotted
with an antibody against VP1.
Found at: doi:10.1371/journal.ppat.1000465.s003 (0.06 MB TIF)
Figure S4 GD1a does not alter the size of endolysosomal
vesicles. (A) The diameters of vesicles containing CFP-Rab5 in
control and GD1a-supplemented cells were measured using an
automated image analysis algorithm written for Image J (NIH).
The fraction of total Rab5 vesicles within indicated vesicle sizes is
shown. (B) As in A, except the diameter of vesicles containing YFP-
Rab7 was analyzed. (C) As in A, except the diameter of vesicles
containing LAMP1-YFP was analyzed. Data are the mean
+/2SD. More than 400 vesicles were analyzed from 3 cells.
Found at: doi:10.1371/journal.ppat.1000465.s004 (0.22 MB TIF)
Figure S5 Image filtering of the ER image. A raw image of the
ER (i.e. expressing CFP-HO2) was subjected to filtering with the
Fast Fourier Transform Bandpass Filter embedded in Image J
(NIH), and pseudocolored. Yellow square, area used for live cell
tracking in Figure 5A. Scale bar, 2 mm.
Found at: doi:10.1371/journal.ppat.1000465.s005 (0.68 MB TIF)
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